Atlas Trials

Genprex, Inc.

4 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Genprex, Inc.

RecordFirmDate
Quaratusugene Ozeplasmid (Reqorsa) and Atezolizumab Maintenance Therapy in ES-SCLC Patients (NCT05703971)Genprex, Inc.2024-05-09
Quaratusugene Ozeplasmid (Reqorsa) in Combination With Pembrolizumab in Previously Treated Non-Small Lung Cancer (NCT05062980)Genprex, Inc.2022-03-30
Quaratusugene Ozeplasmid (Reqorsa) and Osimertinib in Patients With Advanced Lung Cancer Who Progressed on Osimertinib (NCT04486833)Genprex, Inc.2021-09-03

Track Genprex, Inc. automatically

Every clearance here is in the API, with alerts when new ones post.